| Management of paediatric ulcerative colitis, part 1: ambulatory care—an evidence-based guideline from European Crohn's and Colitis Organization and European Society of … D Turner, FM Ruemmele, E Orlanski-Meyer, AM Griffiths, JM De Carpi, ... Journal of pediatric gastroenterology and nutrition 67 (2), 257-291, 2018 | 393 | 2018 |
| Management of paediatric ulcerative colitis, part 2: acute severe colitis—an evidence-based consensus guideline from the European Crohn's and Colitis Organization and the … D Turner, FM Ruemmele, E Orlanski-Meyer, AM Griffiths, JM De Carpi, ... Journal of pediatric gastroenterology and nutrition 67 (2), 292-310, 2018 | 209 | 2018 |
| The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease P Henderson, A Casey, SJ Lawrence, NA Kennedy, K Kingstone, ... Official journal of the American College of Gastroenterology| ACG 107 (6 …, 2012 | 161 | 2012 |
| Higher postinduction infliximab serum trough levels are associated with healing of fistulizing perianal Crohn’s disease in children W El-Matary, TD Walters, HQ Huynh, J deBruyn, DR Mack, K Jacobson, ... Inflammatory Bowel Diseases 25 (1), 150-155, 2019 | 75 | 2019 |
| Canadian Association of Gastroenterology clinical practice guideline for the medical management of pediatric luminal Crohn’s disease DR Mack, EI Benchimol, J Critch, J deBruyn, F Tse, P Moayyedi, P Church, ... Journal of the Canadian Association of Gastroenterology 2 (3), e35-e63, 2019 | 70 | 2019 |
| Phenotypic variation in paediatric inflammatory bowel disease by age: a multicentre prospective inception cohort study of the Canadian Children IBD Network J Dhaliwal, TD Walters, DR Mack, HQ Huynh, K Jacobson, AR Otley, ... Journal of Crohn's and Colitis 14 (4), 445-454, 2020 | 60* | 2020 |
| Management of paediatric patients with medically refractory Crohn’s disease using ustekinumab: a multi-centred cohort study M Chavannes, C Martinez-Vinson, L Hart, N Kaniki, CY Chao, ... Journal of Crohn's and Colitis 13 (5), 578-584, 2019 | 51 | 2019 |
| Diagnostic delay is associated with complicated disease and growth impairment in paediatric Crohn’s disease A Ricciuto, DR Mack, HQ Huynh, K Jacobson, AR Otley, J Debruyn, ... Journal of Crohn's and Colitis 15 (3), 419-431, 2021 | 39 | 2021 |
| Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy ZJ Shire, F Reicherz, S Lawrence, H Sudan, L Golding, A Majdoubi, ... Gut 71 (9), 1922-1924, 2022 | 15 | 2022 |
| Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review SJ Lawrence, M Sadarangani, K Jacobson Frontiers in Pediatrics 5, 161, 2017 | 14 | 2017 |
| The phenotypic spectrum of new-onset IBD in Canadian children of South Asian ethnicity: a prospective multi-centre comparative study J Dhaliwal, MW Carroll, JC Debruyn, A Ricciuto, EI Benchimol, ... Journal of Crohn's and Colitis 16 (2), 216-223, 2022 | 11 | 2022 |
| Allied health professional support in pediatric inflammatory bowel disease: A survey from the Canadian children inflammatory bowel disease network—A joint partnership of CIHR … W El-Matary, EI Benchimol, D Mack, HQ Huynh, J Critch, A Otley, ... Canadian Journal of Gastroenterology and Hepatology 2017, 2017 | 11 | 2017 |
| Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trial N Bollegala, M Barwick, N Fu, AM Griffiths, L Keefer, SA Kohut, KI Kroeker, ... BMC gastroenterology 22 (1), 251, 2022 | 7 | 2022 |
| Optimized infliximab induction predicts better long-term clinical and biomarker outcomes compared to standard induction dosing S Lawrence, F Faytrouni, RE Harris, M Irvine, E Carrion, G Scott, B Clarke, ... Journal of Pediatric Gastroenterology and Nutrition 75 (5), 601-607, 2022 | 5 | 2022 |
| Progression to anti-TNF treatment in very early onset inflammatory bowel disease patients A Eindor-Abarbanel, L Meleady, S Lawrence, Z Hamilton, G Krikler, ... Journal of Pediatric Gastroenterology and Nutrition 75 (4), 473-479, 2022 | 5 | 2022 |
| ADALIMUMAB VERSUS INFLIXIMAB IN LUMINAL PEDIATRIC CROHN'S DISEASE: COMPARABLE OUTCOMES IN A PROSPECTIVE MULTICENTER COHORT STUDY. HQ Huynh, AM Griffiths, K Jacobson, D Mack, C Deslandres, W El-Matary, ... The American Journal of Gastroenterology, 2023 | 3 | 2023 |
| High body mass index is not associated with increased treatment failure in infliximab treated pediatric patients with inflammatory bowel disease I Rodin, J Chan, L Meleady, C Hii, S Lawrence, K Jacobson JGH Open 4 (3), 446-453, 2020 | 3 | 2020 |
| Transition readiness in youth with inflammatory bowel disease A Foster, JM Chan, E Wine, W El-Matary, MW Carroll, KI Kroeker, ... The Journal of Pediatrics 258, 113403, 2023 | 2 | 2023 |
| Discontinuation of immunosuppressive medications in children with inflammatory bowel disease on combination therapy W El-Matary, MW Carroll, JC Debruyn, H Huynh, E Wine, S Lawrence, ... Journal of Pediatric Gastroenterology and Nutrition 71 (6), 740-743, 2020 | 2 | 2020 |
| The value of faecal calprotectin in the investigation of suspected early-onset inflammatory bowel disease SJ Lawrence, P Henderson, A Casey, K Kingstone, P Rogers, PM Gillett, ... Gut 60 (Suppl 1), A149-A150, 2011 | 2 | 2011 |
